Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pacira Pharmaceuticals Inc (NASDAQ:PCRX)

64.42
Delayed Data
As of Aug 03
 0.00 / 0.00%
Today’s Change
57.95
Today|||52-Week Range
121.95
-27.34%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues15.7M39.1M85.6M197.7M
 
 
 
 
 
Cost of Goods Sold12.4M26.5M49.0M67.4M
 
 
 
 
 
Depreciation And Amortization4.3M5.6M5.7M10.0M
 
 
 
 
 
 
Operating ExpensesGross Income-1.1M6.9M30.8M120.2M
 
 
 
 
 
General Expenses35.0M56.2M84.1M125.4M
 
 
 
 
 
Research And Development14.9M9.9M21.6M18.7M
 
 
 
 
 
Total Operating Expenses51.8M88.4M138.8M202.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-36.1M-49.3M-53.3M-5.2M
 
 
 
 
 
Extraordinary Charge-3.0M-1.1M-3.4M0.00
 
 
 
 
Interest Expense On Debt4.8M2.1M9.0M9.0M
 
 
 
 
 
Other Expenses71.0K-111.0K-47.0K-159.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-43.3M-52.3M-64.4M-13.5M
 
 
 
 
 
Income Taxes0.000.00-442.0K-173.0K
 
 
 
Net Income-43.3M-52.3M-63.9M-13.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS16.4M30.3M33.2M35.3M
 
 
 
 
 
Shares To Calculate EPS Diluted16.4M30.3M33.2M35.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.64-$1.72-$1.93-$0.39
 
 
 
 
 
EPS Diluted-$2.64-$1.72-$1.93-$0.39